Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
38.53
-1.94 (-4.79%)
At close: Mar 26, 2026, 4:00 PM EDT
39.18
+0.65 (1.69%)
After-hours: Mar 26, 2026, 7:54 PM EDT

Corcept Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,0993,6885,2973,3592,1902,098
Market Cap Growth
-29.90%-30.38%57.70%53.35%4.41%-31.31%
Enterprise Value
3,5723,3204,9192,9901,7581,874
Last Close Price
38.5334.8050.3932.4820.3119.80
PE Ratio
46.9942.4440.9734.5523.3422.25
Forward PE
94.9055.5332.1132.6119.9521.01
PEG Ratio
-----1.50
PS Ratio
5.384.847.856.965.455.73
PB Ratio
6.305.697.796.634.365.58
P/TBV Ratio
7.146.458.417.164.696.64
P/FCF Ratio
28.9126.0127.0126.5418.2612.53
P/OCF Ratio
28.8625.9726.7126.5118.2012.49
EV/Sales Ratio
4.694.367.296.204.385.12
EV/EBITDA Ratio
77.7572.2735.7127.6115.4414.88
EV/EBIT Ratio
79.7474.1235.9227.8715.6115.06
EV/FCF Ratio
25.2023.4225.0823.6314.6611.19
Debt / Equity Ratio
0.010.010.01000
Debt / EBITDA Ratio
0.130.130.050.000.010.00
Debt / FCF Ratio
0.040.040.040.000.010.00
Net Debt / Equity Ratio
-0.56-0.56-0.55-0.73-0.86-0.59
Net Debt / EBITDA Ratio
-7.97-7.97-2.73-3.40-3.78-1.77
Net Debt / FCF Ratio
-2.58-2.58-1.92-2.91-3.59-1.33
Asset Turnover
0.910.910.920.800.800.74
Inventory Turnover
1.031.031.080.940.971.07
Quick Ratio
2.602.603.114.056.585.28
Current Ratio
2.922.923.354.396.895.60
Return on Equity (ROE)
15.01%15.01%23.81%21.05%23.11%25.03%
Return on Assets (ROA)
8.01%8.01%16.38%15.17%19.52%22.51%
Return on Invested Capital (ROIC)
21.78%21.78%51.37%79.72%84.17%93.83%
Return on Capital Employed (ROCE)
6.54%6.54%22.51%20.87%25.39%27.65%
Earnings Yield
2.40%2.36%2.44%2.89%4.28%4.49%
FCF Yield
3.46%3.84%3.70%3.77%5.48%7.98%
Buyback Yield / Dilution
5.98%5.98%0.54%4.43%0.79%14.43%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q